Know a great AI tool or AI news source? Submit it to AiByts

Why did OpenAI buy a drug development startup?

OpenAI acquired Orchestra Bio, a startup building AI agents that coordinate drug development. When a manufacturing batch fails, its agents find the affected trials, teams and timelines and lay out the options, while people make the final call.

By Aish RegantiAish Reganti
Why did OpenAI buy a drug development startup?

Read the full story

Originally published by Aish Reganti on Nov 4, 2026.

Read on Aish Reganti(opens in a new tab)

Comments

Sign in to join the discussion.

No comments yet — be the first to share your thoughts.